Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity
Authors:
- Dilek GunesDGDilek Gunes
- Günay KirkimGKGünay Kirkim
- Efsun KolatanEKEfsun Kolatan
- Enis Alpin GuneriEGEnis Alpin Guneri
- Candan OzogulCOCandan Ozogul
- Zekiye AltunZAZekiye Altun
- Bülent SerbetciogluBSBülent Serbetcioglu
- Osman YilmazOYOsman Yilmaz
- Safiye AktasSASafiye Aktas
- Kamer MutafogluKMKamer Mutafoglu
- Ozlem TufekciOTOzlem Tufekci
- Zübeyde ErbayraktarZEZübeyde Erbayraktar
- 27 April 2011
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 57 (3) , 186-194
Abstract
Introduction: Cisplatin (CDDP) is an effective and widely used chemotherapeutic agent for pediatric tumors, and ototoxicity is one of the dose-limiting side effects. Objective: It was the aim of our study to investigate the effect of acetyl L-carnitine (ALCAR) on experimental CDDP ototoxicity by audiologic tests, histomorphologic, immunohistochemical and ultrastructural examinations and to investigate the apoptotic pathways. Materials and Methods: Wistar albino rats (n = 28) were studied. Baseline audiological tests were performed in 4 groups: group 1, control; group 2, ALCAR; group 3, CDDP; group 4, CDDP + ALCAR-administered rats. Control audiological tests were performed on the 3rd day, and then the rats were sacrificed. Ear and brain specimens were examined by transmission electron microscopy, and caspase 3, 8 and 9 activities were investigated. Results: The CDDP-administered rats showed significant auditory brainstem response threshold shifts using all stimuli (clicks, 6-kHz and 8-kHz tone burst) compared with the control groups. The CDDP + ALCAR-administered rats showed significant auditory brainstem response threshold shifts by only click stimuli compared with the control groups. In the brain, spiral ganglion and organ of Corti, ultrastructural damage was prominent in group 3; the number of TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling)-positive cells and caspase 3, 8 and 9 immunostaining cells was significantly high in group 3. Conclusion: ALCAR improves CDDP-induced auditory impairment, and also antioxidative and antiapoptotic properties of ALCAR on CDDP ototoxicity were supported by the findings.Keywords
This publication has 32 references indexed in Scilit:
- Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin NephrotoxicityChemotherapy, 2009
- Protective Effects of Acetyl-l-Carnitine on Cisplatin Cytotoxicity and Oxidative Stress in NeuroblastomaNeurochemical Research, 2009
- Continuous or intermittent noise exposure, does it cause vestibular damage?Auris Nasus Larynx, 2009
- Protective effect of acetyl‐l‐carnitine on the apoptotic pathway of peripheral neuropathyEuropean Journal of Neuroscience, 2007
- Acetyl-L-Carnitine for the Treatment of Chemotherapy-Induced Peripheral NeuropathyCNS Drugs, 2007
- Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genesThe Journal of Nutritional Biochemistry, 2006
- Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitineEuropean Journal of Cancer, 2005
- Best practice in assessing ototoxicity in children with cancerEuropean Journal of Cancer, 2004
- The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeabilityCell Death & Differentiation, 2000
- Hearing loss in children receiving cisplatin chemotherapyThe Journal of Pediatrics, 1983